Fiche publication


Date publication

octobre 2024

Journal

ACS infectious diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BECHINGER Burkhard


Tous les auteurs :
Guerinot C, Malige M, De K, Maresca M, Charbonnel N, Courvoisier-Dezord E, Vidal N, Roy O, Laurent F, Josse J, Aisenbrey C, Bechinger B, Forestier C, Faure S

Résumé

Bioinspired from cationic antimicrobial peptides, sequence-defined triazolium-grafted peptoid oligomers (6- to 12-mer) were designed to adopt an amphipathic helical polyproline I-type structure. Their evaluation on a panel of bacterial strains (, , , and ), pathogenic fungi (, , and ), and human cells (hRBC, BEAS-2B, Caco-2, HaCaT, and HepG2) enabled the identification of two heptamers with improved activity to selectively fight pathogens. Modulation of parameters such as the nature of the triazolium and hydrophobic/lipophilic side chains, the charge content, and the sequence length drastically potentiates activity and selectivity. Besides, the ability to block the proinflammatory effect induced by lipopolysaccharide or lipoteichoic acid was also explored. Finally, biophysical studies by circular dichroism and fluorescence spectroscopies strongly supported that the bactericidal effect of these triazolium-grafted oligomers was primarily due to the selective disruption of the bacterial membrane.

Mots clés

antifungal, antimicrobial, membrane permeability, peptidomimetic, selectivity, triazolium

Référence

ACS Infect Dis. 2024 10 11;: